Clin2
NCT07779252Possibly a fitNot yet recruiting

Study of a new treatment for frown lines between the eyebrows

Moderate to Severe Glabellar Lines

This study tests a new medication (IPN10200) to safely reduce moderate to severe frown lines between the eyebrows in adults. It may help if you are bothered by these lines and are looking for a non-surgical option.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 3
Enrollment
160 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You are 18 years or older.
  • Your frown lines between the eyebrows are moderate to severe (grade 2 or 3).
  • You are dissatisfied or very dissatisfied with these lines.
  • You have not had Botox or similar injections in any part of your body for at least 9 months.
  • You do not have any active skin infections or recent surgeries in the upper face area.
  • You are willing to follow the study rules and use birth control if you are a woman who can become pregnant.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07427797Recruiting· Phase 3
Study of a treatment for frown lines between the eyebrows

This study tests a new medicine (IPN10200) to see how well it works and how safe it is for reducing moderate to severe frown lines between the eyebrows in adults. If you are unhappy with the appearance of these lines, this trial may help.

Birmingham, Alabama
NCT07435428Recruiting· Phase 3
Study of a new treatment for moderate to severe frown lines between eyebrows

This trial tests a new medication's effectiveness and safety over time in adults with moderate to severe frown lines between the eyebrows. It aims to see if the treatment can reduce these lines and improve satisfaction with appearance.

Los Angeles, California
NCT06937944Recruiting· Phase 3
New Botox-like injection for frown lines

This study tests a new botulinum toxin injection (similar to Botox) to see how well it smooths moderate to severe frown lines between the eyebrows. The treatment is given as a single injection and may help soften those lines for several months.

Beijing, Beijing Municipality
NCT07756580Not yet recruiting· Phase 1
Study of injections for frown lines between the eyebrows

This study tests two different injection treatments for moderate to severe frown lines between the eyebrows. It aims to find the best way to use these treatments to improve your appearance.

NCT06205797Recruiting· Phase 3
Study of a new treatment for frown lines between the eyebrows

This trial tests an injection called HU-045 to reduce moderate to severe frown lines. It may help adults who want to soften those vertical lines between the eyebrows.

Seoul
NCT07730554Recruiting· Phase 2
Study of injections for forehead and frown lines

This trial tests an injectable treatment for moderate to severe forehead lines and frown lines in adults. It aims to see if the injections can safely reduce the appearance of these lines.

Newport Beach, California

Hear when a new Moderate to Severe Glabellar Lines trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.